T L Andresen

Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective.

S M Moghimi, A C Hunter, T L Andresen, 2012, Annual review of pharmacology and toxicology.

Complement activation cascade triggered by PEG-PL engineered nanomedicines and carbon nanotubes: the challenges ahead.

J Szebeni, S M Moghimi, A C Hunter, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Complement-mediated tumour growth: implications for cancer nanotechnology and nanomedicines.

S M Moghimi, T L Andresen, T. Andresen, 2009, Molecular immunology.

Interdependence of initial cell density, drug concentration and exposure time revealed by real-time impedance spectroscopic cytotoxicity assay.

J Emnéus, M Carminati, T L Andresen, 2015, The Analyst.